Concepedia

Chethana Kulkarni

CK

5

Publications

163

Citations

5

H-Index

2013

Active since

Affiliations

Pfizer (United States)(Current)

California Institute of Technology

Purdue University West Lafayette

Massachusetts Institute of Technology

Chethana Kulkarni is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2013–2017

5

Publications

5

Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design

Katie F. Maass, Chethana Kulkarni, Alison Betts et al. · The AAPS Journal · 2016 · 75 citations · Full text

, , +10

Selective Functionalization of the Protein N Terminus with N‐Myristoyl Transferase for Bioconjugation in Cell Lysate

Chethana Kulkarni, Tamara L. Kinzer‐Ursem, David A. Tirrell · ChemBioChem · 2013 · 40 citations

Bioorthogonal Chemoenzymatic Functionalization of Calmodulin for Bioconjugation Applications

Chethana Kulkarni, Megan Lo, Julia G. Fraseur et al. · Bioconjugate Chemistry · 2015 · 19 citations

A Flow Cytometric Clonogenic Assay Reveals the Single-Cell Potency of Doxorubicin

Katie F. Maass, Chethana Kulkarni, Mohiuddin Quadir et al. · Journal of Pharmaceutical Sciences · 2015 · 15 citations · Full text

, , +6

Development of Fluorophore-Labeled Thailanstatin Antibody-Drug Conjugates for Cellular Trafficking Studies

Chethana Kulkarni, James E. Finley, Andrew J. Bessire et al. · Bioconjugate Chemistry · 2017 · 14 citations

Rows per page

1–5 of 5